Mesenchymal Stromal Cells Do Not Increase the Risk of Viral Reactivation Nor the Severity of Viral Events in Recipients of Allogeneic Stem Cell Transplantation

Mesenchymal stromal cells (MSC) are tested in clinical trials to treat graft versus host disease (GvHD) after stem cell transplantation (SCT). In vitro studies demonstrated MSC's broad immunosuppressive activity. As infections represent a major risk after SCT, it is important to understand the...

Full beskrivning

Sparad:
Bibliografiska uppgifter
Huvudupphovsmän: Lucchini, Giovanna, Dander, Erica, Pavan, Fabio, Di Ceglie, Irene, Balduzzi, Adriana, Perseghin, Paolo, Gaipa, Giuseppe, Algarotti, Alessandra, Introna, Martino, Rambaldi, Alessandro, Rovelli, Attilio, Biondi, Andrea, Biagi, Ettore, D'Amico, Giovanna
Materialtyp: Artigo
Språk:Inglês
Publicerad: Hindawi Publishing Corporation 2012
Ämnen:
Clinical Study
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC3369546/
https://ncbi.nlm.nih.gov/pubmed/22701127
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2012/690236
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk